Transplant Diagnostics Market Forecast and Analysis - Growth Factors, Business Developments, Segmentation and Technologies
The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%. Geographically, the transplant diagnostics market is segmented into North America, Europe, Asia Pacific, and the Rest
(EMAILWIRE.COM, December 08, 2018 ) Report studies the transplant diagnostics market based on technology, product, transplant type, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders.
Download Sample Papers of Transplant Diagnostics Market spread across 221 Pages, Profiling 16 Companies and Supported with 122 Tables and 47 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=354225 .
Transplant diagnostics market report covers across four major regions, namely, North America, Europe, Asia Pacific, and the RoW. North America is expected to command the largest share of the market in 2018. The large share of North America in the global transplant diagnostics market is attributed to the high budgetary allocation for healthcare expenditure, large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics.
Stakeholders of Transplant Diagnostics Market are Transplant diagnostics product manufacturing companies, Healthcare service providers (including hospitals, transplant centers, and blood transfusion centers), Blood, tissue, and stem cell banks, Government organizations, Independent associations and regulatory authorities, R&D companies, Independent reference laboratories, Diagnostic laboratories, Clinical research organizations, Research laboratories and academic institutes.
Transplant diagnostics market is segmented into molecular (PCR based assay and sequencing based assay technologies) and non-molecular assays. The molecular assay technology segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the technological benefits of molecular assays such a slow turnaround time, high procedural efficacy, study of multiple samples, and real-time sample analysis.
Order the Copy of Global Transplant Diagnostics Market Research Report Now at http://www.reportsnreports.com/purchase.aspx?name=354225 .
Geographically, the transplant diagnostics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC transplant diagnostics market can be attributed to the increasing adoption of cutting-edge diagnostic technologies among medical professionals, rapid rise in geriatric population (especially in Japan and China), and universal government healthcare coverage in Japan (including for transplantation & related diagnostic procedures).
Global transplant diagnostics market is competitive, with a large number of global and local players. In 2017, the market was dominated by Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and Immucor, Inc. (US). Product launches, market expansions, strategic acquisitions, and partnerships, agreements,& collaborations were the major strategies adopted by market players to achieve growth in the market.
Click now for more Details, Queries, Other Information on this study Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) Global Forecast to 2023 research report now at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=354225 .
Transplant diagnostics market is segmented into three categories, namely, independent reference laboratories, hospitals and transplant centers, and research laboratories & academic institutes. In 2018, the independent reference laboratories segment is expected to account for the largest share of the market due to increasing global demand for infectious disease diagnosis and tissue typing during donor-recipient profiling/cross-matching.
Breakdown of supply-side primary interviews: by company type, designation, and region:
By Company Type - Tier 1 25%, Tier 2 30% and Tier 3 45%
By Designation C-level 26%, Director-level 30%, Others 44%
By Region North America - 34%, Europe 26%, APAC 23%, RoW 17%
Highest CAGR for the APAC transplant diagnostics market can be attributed to the increasing adoption of cutting-edge diagnostic technologies among medical professionals, rapid rise in geriatric population (especially in Japan and China), and universal government healthcare coverage in Japan (including for transplantation & related diagnostic procedures).
Download Sample Papers of Transplant Diagnostics Market spread across 221 Pages, Profiling 16 Companies and Supported with 122 Tables and 47 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=354225 .
Transplant diagnostics market report covers across four major regions, namely, North America, Europe, Asia Pacific, and the RoW. North America is expected to command the largest share of the market in 2018. The large share of North America in the global transplant diagnostics market is attributed to the high budgetary allocation for healthcare expenditure, large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics.
Stakeholders of Transplant Diagnostics Market are Transplant diagnostics product manufacturing companies, Healthcare service providers (including hospitals, transplant centers, and blood transfusion centers), Blood, tissue, and stem cell banks, Government organizations, Independent associations and regulatory authorities, R&D companies, Independent reference laboratories, Diagnostic laboratories, Clinical research organizations, Research laboratories and academic institutes.
Transplant diagnostics market is segmented into molecular (PCR based assay and sequencing based assay technologies) and non-molecular assays. The molecular assay technology segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the technological benefits of molecular assays such a slow turnaround time, high procedural efficacy, study of multiple samples, and real-time sample analysis.
Order the Copy of Global Transplant Diagnostics Market Research Report Now at http://www.reportsnreports.com/purchase.aspx?name=354225 .
Geographically, the transplant diagnostics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC transplant diagnostics market can be attributed to the increasing adoption of cutting-edge diagnostic technologies among medical professionals, rapid rise in geriatric population (especially in Japan and China), and universal government healthcare coverage in Japan (including for transplantation & related diagnostic procedures).
Global transplant diagnostics market is competitive, with a large number of global and local players. In 2017, the market was dominated by Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and Immucor, Inc. (US). Product launches, market expansions, strategic acquisitions, and partnerships, agreements,& collaborations were the major strategies adopted by market players to achieve growth in the market.
Click now for more Details, Queries, Other Information on this study Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Stem Cell), End User (Hospital) Global Forecast to 2023 research report now at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=354225 .
Transplant diagnostics market is segmented into three categories, namely, independent reference laboratories, hospitals and transplant centers, and research laboratories & academic institutes. In 2018, the independent reference laboratories segment is expected to account for the largest share of the market due to increasing global demand for infectious disease diagnosis and tissue typing during donor-recipient profiling/cross-matching.
Breakdown of supply-side primary interviews: by company type, designation, and region:
By Company Type - Tier 1 25%, Tier 2 30% and Tier 3 45%
By Designation C-level 26%, Director-level 30%, Others 44%
By Region North America - 34%, Europe 26%, APAC 23%, RoW 17%
Highest CAGR for the APAC transplant diagnostics market can be attributed to the increasing adoption of cutting-edge diagnostic technologies among medical professionals, rapid rise in geriatric population (especially in Japan and China), and universal government healthcare coverage in Japan (including for transplantation & related diagnostic procedures).
Contact Information:
ReportsnReports
Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results